Substrate selectivity and catalytic activation of the type III CRISPR ancillary nuclease Can2
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkad1102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Kenny Jungfer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: CRISPR-Associated Proteins, Endoribonucleases, Thermoanaerobacter. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, University of Zurich.
Abstract (Originalsprache)
Type III CRISPR-Cas systems provide adaptive immunity against foreign mobile genetic elements through RNA-guided interference. Sequence-specific recognition of RNA targets by the type III effector complex triggers the generation of cyclic oligoadenylate (cOA) second messengers that activate ancillary effector proteins, thus reinforcing the host immune response. The ancillary nuclease Can2 is activated by cyclic tetra-AMP (cA4); however, the mechanisms underlying cA4-mediated activation and substrate selectivity remain elusive. Here we report crystal structures of Thermoanaerobacter brockii Can2 (TbrCan2) in substrate- and product-bound complexes. We show that TbrCan2 is a single strand-selective DNase and RNase that binds substrates via a conserved SxTTS active site motif, and reveal molecular interactions underpinning its sequence preference for CA dinucleotides. Furthermore, we identify a molecular interaction relay linking the cA4 binding site and the nuclease catalytic site to enable divalent metal cation coordination and catalytic activation. These findings provide key insights into the molecular mechanisms of Can2 nucleases in type III CRISPR-Cas immunity and may guide their technological development for nucleic acid detection applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Kenny Jungfer, Annina Sigg, Martin Jinek
Förderung
- European Research Council
- University of Zurich
Zitieren
APA
Jungfer, K., Sigg, A., & Jinek, M. (2024). Substrate selectivity and catalytic activation of the type III CRISPR ancillary nuclease Can2. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad1102
Vancouver
Jungfer K, Sigg A, Jinek M. Substrate selectivity and catalytic activation of the type III CRISPR ancillary nuclease Can2. Nucleic Acids Research. 2024. doi:10.1093/nar/gkad1102
BibTeX
@article{Jungfer2024,
author = {Jungfer, Kenny and Sigg, Annina and Jinek, Martin},
title = {Substrate selectivity and catalytic activation of the type III CRISPR ancillary nuclease Can2},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkad1102}
}
EUVIMED